Yale SPORE in Skin Cancer

Download for more details

The Yale SPORE in Skin Cancer is a multidisciplinary, clinically translational program focused on two skin cancers, basal cell carcinoma (BCC) and melanoma. Targeting these two skin cancers is important because one million BCC cases are newly diagnosed every year in the USA and melanoma is the 5th most common cancer, together constituting 5% of total cancer incidence. The SPORE includes over 50 investigators with diverse interests drawn from basic and clinical departments at Yale. The major translational goals are in developing preventive interventions aimed at reducing the incidence of early and total BCC, the introduction of new molecular tools for assessing responses to melanoma therapy, developing serological markers, application of new approaches to personalize melanoma chemo- and immuno-therapy, the establishment of a composite databases for skin cancers and the creation of new translational bioinformatics tools required to analyze global and highly complex information derived from different sources and different platforms.